Sawai Pharmaceutical completes acquisition of Upsher-Smith Laboratories’ generics business. Sawai Pharmaceutical Co., Ltd., (Sawai) and Upsher-Smith Laboratories, LLC (Upsher-Smith) announced that Sawai, a leading Japanese generic pharmaceuticals manufacturer, has successfully completed its acquisition of Upsher-Smith’s generics business. Sawai intends to retain operations in Minnesota and Colorado. As previously announced, the acquisition provides Sawai with an opportunity for growth…